A classification system categorizes invasive breast carcinomas into four distinct molecular subtypes, luminal A, luminal B, human epidermal growth factor receptor-2 (HER2)-over-expressing and basal-like, which provide a clinically useful basis for therapeutic selection[1]. The gene discussed is ERBB2; the disease is invasive breast carcinoma.